NWNae Yeon Won

Nae Yeon Won

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nae Yeon Won has a total of 43 co-authors. Here are the top co-authors by number of shared publications:

  • Linda B. Cottler

    Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida

    3 shared publications
  • Catherine W. Striley

    Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida

    2 shared publications
  • Linda B. Cottler

    Department of Epidemiology, College of Public Health and Health Professions, College of Medicine, University of Florida, Gainesville, Florida

    2 shared publications
  • Alexandra Paul

    Department of Orthopaedic Surgery, Duke University Medical Center, Durham, NC, USA

    1 shared publication
  • Andrew J. McCabe

    Department of Epidemiology, College of Public Health and Health Professions, College of Medicine, University of Florida, USA

    1 shared publication
  • Anna Wang

    Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida

    1 shared publication

Latest Publications

  • Substance-related fatal motor vehicle crashes in Maryland: a preliminary toxicological analysis (2024–2025)

    by Nae Y Won, Stephanie Haddad, Wendy Shields, Stephanie Dean, Rebecca Phipps, Ling Li, Renee M Johnson

    Background: In 2023, Maryland legalized recreational cannabis use; however, understanding of cannabis involvement in motor vehicle crashes (MVCs) remains limited. We examined toxicology findings, including routine cannabis testing, and crash circumstances among drivers fatally injured in MVCs in Maryland. Methods: We evaluated data from death investigation reports by the Maryland Office of the Chief Medical Examiner in Baltimore on drivers fatally injured in MVCs between October 2024 and March 2025. Routine comprehensive toxicology screening covered more than 100 substances, including alcohol and illicit drugs. Delta-9-tetrahydrocannabinol (THC), the active impairing ingredient in cannabis, was also detected using ELISA and confirmed by liquid chromatography tandem mass spectrometry. Any confirmed substances were considered positive. We defined a positive alcohol result as a blood alcohol concentration ≥0.08 g/100 mL, based on the legal limit for driving in Maryland. We calculated frequencies of single-substance and multi-substance toxicology results. Results: There were 90 fatally injured drivers. One-third (n=30) tested positive for alcohol, 30% (n=27) tested positive for THC and 40% (n=36) for other drugs, of which 18.9% were illicit drugs. 12 of the 30 alcohol-positive decedents (40%) were THC-positive. 15 decedents (16.7%) were positive for involved alcohol only, 22 (24.4%) were positive for other drugs only and 14 (15.6%) were positive for alcohol and/or THC with other drugs. Conclusion: One-third of fatally injured drivers in Maryland tested positive for THC, and nearly half of alcohol-involved cases also involved THC. Routine THC testing in crash death investigations is essential for characterising substance-related crashes and informing prevention strategies.

  • Edible cannabis use on simulated driving performance

    by Nae Y. Won, Sarah Bird, Julia Wrobel, Timothy Brown, Ashley Brooks-Russell

    To assess driving performance after consuming edible cannabis using a driving simulator, examining frequency of use, THC dose, and rural versus urban settings. Adults in Denver, Colorado (N = 88), between 25 and 55 years old, were recruited from November 2023 to July 2024 and assigned to groups based on past 90-day cannabis use: daily (N = 29), occasional (N = 30), or no recent use (i.e., comparison group; N = 29). This within-subjects study compared driving performance (i.e., speed, lane departures per minute, and standard deviation of lateral placement (SDLP)) using a validated driving simulator (miniSim™) at baseline and two post-consumption tests (52 and 119 min). Linear mixed models were used to evaluate performance. Daily-use group drove slower than the occasional-use group (decrease in average speed from pretest of 2.49 mph (urban, p < 0.01 post-1); 1.80 mph (p = 0.02 post-2)) and the comparison group (decrease in average speed from pretest of 2.70 mph (urban, p < 0.01 post-1); 2.68 mph (urban, p < 0.01 post-2)). Lane departures increased in the occasional-use group from 0.17 at pretest to 0.47 in post-1 and 0.40 in post-2 (p < 0.01). Their rural SDLP increased: post-1 (29.37 cm, p < 0.01), post-2 (29.81 cm, p < 0.01), versus pretest (25.45 cm). This group had significantly greater change in lane departures than both the comparison group (0.26, p < 0.01) and daily-use group (0.34, p < 0.01) in post-1. In post-2, the change remained greater than the daily-use group (0.20, p = 0.02). Our study found significant changes in driving performance following edible cannabis use, including findings related to effect duration, use frequency, and road settings. The occasional-use group showed greater impairment than daily-use group, suggesting tolerance contributes to outcomes beyond THC concentration alone.


  • Geographical Differences in Self-Reported Past 12-Month Drug Use: Results from the NDEWS Rapid Street Reporting, 2021–2023

    by Nae Y. Won, Anna Wang, Ryan Athay, Catherine W. Striley, Linda B. Cottler

    The National Drug Early Warning System Rapid Street Reporting study monitors over 100 drugs to identify emerging use trends. This analysis examined geographical differences in the past 12-month self-reported drug use across 20 US urban cities, identifying the three most prevalent drugs reported, excluding alcohol. Adults (age ≥18) were surveyed in public settings using venue-intercept sampling over a weekend in each city between January 2022 and November 2023 regarding past 12-month drug use. We focused on the three most commonly reported drugs in each region. The prevalence of reported drug use by region was compared using generalized linear models with Poisson and log-link functions, adjusting for participant characteristics, time of year, and location. Among 6,039 participants, cannabis for recreational use (50.3%), psilocybin (13.7%), and cocaine (11.0%) were the most commonly reported drugs used. While there were no regional differences in the prevalence of recreational cannabis use, psilocybin, and cocaine use were more commonly reported by people in the West versus the Midwest (adjusted prevalence ratio [aPR]=1.58, 95% confidence interval [CI]: 1.23, 2.06; aPR=1.67, 95% CI: 1.26, 2.23, respectively). We also found a higher prevalence of cocaine use reported by participants in the Northeast compared to participants in the Midwest (aPR=1.37, 95% CI: 1.00, 1.91). Venue intercept survey method detected signals of recreational cannabis, psilocybin, and cocaine use in the 20 US urban cities visited over a weekend. Reported prevalence differed by region. This suggests that prevention messaging should be tailored to the specific US regions.


  • Drug use among individuals injured in non-fatal motor vehicle crashes and related policies in 2023

    by Nae Y. Won, Kelly K. Gurka, Catherine W. Striley, Sara Jo Nixon, Linda B. Cottler

    Although driving-related policies aimed at mitigating drug-related motor vehicle crashes (MVCs) have been implemented in diverse communities, data regarding their effectiveness are largely absent. A comprehensive evaluation of these policies is necessary. Furthermore, as US states legalize the recreational use of cannabis, the impact of these policies on drug-related crashes also needs to be evaluated. The objective was to assess the association between drug use prevalence among individuals (age 16+) injured in non-fatal MVCs in 2023 and various related policies, including drug-impaired driving policies, sobriety checkpoints, enforcement programs, and state cannabis legalization status. We analyzed 2023 emergency medical services (EMS) records of individuals (age 16+) injured in non-fatal MVCs across 19 US states where EMS personnel indicated drug use, excluding duplicate, incomplete, and alcohol-only records. Using these counts, we calculated the prevalence of drug use among individuals (age 16+) injured in non-fatal MVCs in each state. The association between drug use prevalence and state-level policies, including drug-impaired driving laws (i.e., per se or zero tolerance), sobriety checkpoints, enforcement programs, and cannabis legalization laws, was evaluated using adjusted Poisson regression with random effects for state differences. Policies were assessed individually and in a full model to evaluate their individual and additive effects. In 2023, 11,538 individuals (68.2% male) were injured in drug-related non-fatal crashes. Neither drug-impaired driving policies, the use of sobriety checkpoints, nor the implementation of State Judicial Outreach Liaisons influenced the prevalence of drug use among individuals injured in non-fatal crashes. In contrast, relative to states with no policy or cannabidiol/low tetrahydrocannabinol, those permitting recreational cannabis had significantly higher prevalence (adjusted prevalence ratio [aPR]: 1.57, 95% confidence interval [CI]: 1.22, 2.02). The implementation of sobriety checkpoints was associated with higher drug use prevalence (aPR: 1.59, 95% CI: 1.22, 2.09) when drug-impaired driving policies were absent, particularly in states permitting recreational cannabis. Our findings show differences in drug use prevalence among individuals (age 16+) injured in non-fatal MVCs based on state-level policies, highlighting the need for holistic enforcement strategies to address drug-related crashes, especially amid the increasing risks associated with the legalization of recreational cannabis use.


  • Willingness to provide a hair sample for drug testing: results from an anonymous multi-city intercept survey

    by Nae Y. Won, Brittney Jabot, Anna Wang, Joseph J. Palamar, Linda B. Cottler

    Background: Hair provision for drug testing can provide secondary measurement to complement self-reported drug use data, thereby providing a more accurate representation of an individual's drug use. Understanding factors associated with hair provision offers valuable insights into recruitment methods.Objective: To identify demographic and drug-related correlates of providing hair samples in a multi-site venue-intercept study.Methods: We utilized venue-intercept sampling for our Rapid Street Reporting study across 12 US cities between January and November 2022. Participants reported past 12-month drug use and were asked if they would provide a hair sample. We conducted multivariable (generalized linear model with logit link) analyses on demographics and drug use characteristics correlated to hair provision for drug testing.Results: Among 3,045 participants, 55.8% were male, 13.6% provided hair samples. Compared to males, those identifying as "other gender" had higher odds of hair collection (adjusted odds ratio = 2.24, 95% confidence interval: 1.28-3.80). Participants identifying as Black (aOR = 0.32, CI: 0.23-0.45) or "other race" (aOR = 0.50, 95% CI: 0.29-0.80) had lower odds of providing hair than those identifying as White. All levels of reported drug use - one drug (aOR=1.50, 95% CI: 1.15-1.96), two-three drugs (aOR=1.51, 95% CI: 1.11-2.05), four or more (aOR = 2.13, 95% CI: 1.50-3.01) - had higher odds of providing hair samples than those reporting no drug use. Similar associations applied to reporting cannabis use with or without another drug (aOR = 1.52-1.81, 95% CI: 1.15-2.38).Conclusion: Differential hair provision based on participant sex, race/ethnicity, and drug use may introduce biases in drug testing, limiting generalizability to individuals from minority backgrounds.


  • Alcohol-related non-fatal motor vehicle crash injury in the US from 2019 to 2022

    by Nae Y. Won, Andrew J. McCabe, Linda B. Cottler

    Background: Information on recent alcohol-related non-fatal motor vehicle crash (MVC) injuries is limited.Objectives: To analyze alcohol-related non-fatal MVC injuries, 2019-2022, considering COVID-19 and Stay-at-Home policies.Methods: State-level counts of alcohol-related non-fatal MVC injuries (involving individuals age 15+) from Emergency Medical Services data in 18 US states, chosen for comprehensive coverage, were analyzed for the annual rate. The total non-fatal MVC injury count in each state served as the denominator. We used analysis of variance to evaluate annual rate changes from 2019 to 2022 and used robust Poisson regression to compare annual mean rates to the 2019 baseline, pre-pandemic, excluding Quarter 1 due to COVID-19's onset in Quarter 2. Additional Poisson models compared rate changes by 2020 Stay-at-Home policies.Results: Data from 18 states were utilized (N = 1,487,626, 49.5% male). When evaluating rate changes of alcohol-related non-fatal MVC injuries from period 1 (Q2-4 2019) through period 4 (Q2-4 2022), the rate significantly increased from period 1 (2019) to period 2 (2020) by 0.024 (p = .003), then decreased from period 2 to period 4 (2022) by 0.016 (p = .04). Compared to the baseline (period 1), the rate in period 2 was 1.27 times higher. States with a 2020 Stay-at-Home policy, compared to those without, had a 30% lower rate (p = .05) of alcohol-related non-fatal MVC injuries. States with partial and mandatory Stay-at-Home policies had a 5.2% (p = .01) and 10.5% (p < .001) annual rate decrease, respectively.Conclusion: Alcohol-related non-fatal MVC injury rates increased initially (2019-2020) but decreased thereafter (2020-2022). Stay-at-home policies effectively reduced these rates.


  • Open Access

    A Qualitative Analysis of Emergency Medical Services Personnel Experiences and Perception Responding to Drug Overdoses in the US during the COVID-19 Pandemic

    by Nae Y. Won, Joseph J. Palamar, Stephen A. Mike, Nicole D. Fitzgerald, Linda B. Cottler

    Background: The purpose of this work was to describe the experiences of EMS personnel in responding to drug overdose-related calls and the impact the pandemic has had to help better inform current response and treatment efforts. Methods: Semi-structured interviews were conducted with 99 EMS personnel across 18 areas throughout the United States that were designated as Early Warning Network sentinel sites by the National Institute on Drug Abuse-funded National Drug Early Warning System. Participants were asked about topics including the potential burdens from the pandemic and the opioid crisis. We coded the interview responses and identified themes through qualitative analysis. Multiple cycles of descriptive coding, recoding, subcoding, pattern-coding, and thematic coding of responses were conducted. Results: Responses were categorized into the following themes: 1) being over-worked from increased call volume; 2) increased risk for personal harm when responding to patients; 3) compassion fatigue due to long hours and repeat calls for the same people; 4) conflicting perceptions of the utility of naloxone; 5) the need for better treatment options to respond to opioid crisis on top of COVID-19. Conclusions: The burden of the substance use disorder (SUD) crisis on EMS personnel has been compounded by the COVID-19 pandemic. These reports from EMS personnel throughout the US can help inform policy and procedures to better protect the mental health of EMS personnel and to ensure better care for patients with SUD. These experiences and recommendations may be of use for other countries as substance use and COVID-19 are global health issues. Keywords: Emergency medical services, Substance use, Opioids, Overdose, COVID-19, Prehospital care


  • Scoping review to evaluate existing measurement parameters and clinical outcomes of transtibial prosthetic alignment and socket fit

    by Nae Yeon Won, Alexandra Paul, Matthew Garibaldi, Rita E. Baumgartner, Kenton R. Kaufman, Lisa Reider, Jordan Wrigley, Saam Morshed

    Introduction: Fit and alignment are observable objectives of the prosthesis rendering process for individuals with lower limb amputation. Nevertheless, there is a dearth of validated measures to directly assess the quality of this clinical procedure. Objectives: The objectives of this scoping review are to evaluate existing measurement parameters and clinical outcomes used in investigations of transtibial socket fit or prosthetic alignment and to identify gaps in the literature regarding tools for evaluation of prosthetic fitting. Study design: Scoping literature review. Methods: A comprehensive search was conducted in the following databases: MEDLINE (through PubMed), Embase (through Elsevier), Scopus (through Elsevier), and Engineering Village (through Elsevier), resulting in 6107 studies to be screened. Results: Sixty-three studies were included in the review. When measuring fit, studies most frequently reported on patient-reported comfort (n = 22) and socket size compared with the residual limb volume (n = 9). Alignment was most frequently measured by the prosthetists' judgment and/or use of an alignment jig (n = 34). The measurement parameters used to determine alignment or fit varied greatly among the included studies. Conclusion: This review demonstrated that most measures of socket fit rely on a patient's self-report and may vary with biopsychosocial factors unrelated to the socket fitting process. Meanwhile, alignment is determined mostly by the prosthetist's judgment, paired with objective measurements, such as alignment jigs and gait analysis. Efforts to standardize and validate measures of these parameters of prosthetic fitting are vital to improving clinical practice and reporting outcomes.


  • Barriers and facilitators for cascade testing in genetic conditions: a systematic review

    by Swetha Srinivasan, Nae Yeon Won, W. David Dotson, Sarah T. Wright, Megan C. Roberts

    Cascade testing is the process of offering genetic counseling and testing to at-risk relatives of an individual who has been diagnosed with a genetic condition. It is critical for increasing the identification rates of individuals with these conditions and the uptake of appropriate preventive health services. The process of cascade testing is highly varied in clinical practice, and a comprehensive understanding of factors that hinder or enhance its implementation is necessary to improve this process. We conducted a systematic review to identify barriers and facilitators for cascade testing and searched PubMed, CINAHL via EBSCO, Web of Science, EMBASE, and the Cochrane Library for articles published from the databases’ inception to November 2018. Thirty articles met inclusion criteria. Barriers and facilitators identified from these studies at the individual-level were organized into the following categories: (1) demographics, (2) knowledge, (3) attitudes, beliefs, and emotional responses of the individual, and (4) perceptions of relatives, relatives’ responses, and attitudes toward relatives. At the interpersonal-level, barriers and facilitators were categorized as (1) family communication-, support- and dynamics-, and (2) provider-factors. Finally, barriers at the environmental-level relating to accessibility of genetic services were also identified. Our findings suggest that several individual, interpersonal and environmental factors may play a role in cascade testing. Future studies to further investigate these barriers and facilitators are needed to inform future interventions for improving the implementation of cascade testing for genetic conditions in clinical practice.


  • Open Access

    Resident Rotations in Low- and Middle-Income Countries

    by Claire A. Donnelley, Nae Won, Heather J. Roberts, Ericka P. von Kaeppler, Patrick D. Albright, Pierre Marie Woolley, Billy Haonga, David W. Shearer, Sanjeev Sabharwal

    Introduction: Interest in clinical rotations in low- and middle-income countries (LMICs) has grown among high-income country (HIC) orthopaedic residents. This study addresses the following questions: (1) What motivates HIC surgical residents to rotate in LMICs? (2) What is the impact of rotations on HIC residents? (3) What are the LMIC partner perceptions of HIC collaboration? Materials and Methods: A search strategy of multiple databases returned 3,740 unique articles pertaining to HIC surgical resident motivations for participating in rotations in LMICs or the LMIC host perspective. Data extraction was dually performed using meta-ethnography, the qualitative equivalent of meta-analysis. Results: Twenty-one studies were included in the final analysis. HIC residents were primarily motivated to rotate in LMICs by altruistic intent, with greatest impact on professional development. LMIC partners mostly valued HIC sustained investment and educational opportunities for LMIC partners. From LMIC's perspective, potential harm from collaboration arose from system-level and individual-level discordance between HIC and LMIC expectations and priorities. HIC priorities included the following: (1) adequate operative time, (2) exposure to varied pathology, and (3) mentorship. LMIC priorities included the following: (1) avoiding competition with HIC residents for surgical cases, (2) that HIC groups not undermine LMIC internal authority, (3) that HIC initiatives address local LMIC needs, and (4) that LMIC partners be included as authors on HIC research initiatives. Both HIC and LMIC partners raised ethical concerns regarding collaboration and perceived HIC residents to be underprepared for their LMIC rotation. Discussion: This study synthesizes the available literature on HIC surgical resident motivations for and impact of rotating in LMICs and the LMIC host perception of collaboration. Three improvement categories emerged: that residents (1) receive site-specific preparation before departure, (2) remain in country long enough to develop site-specific skills, and (3) cultivate flexibility and cultural humility. Specific suggestions based on synthesized data are offered for each concept and can serve as a foundation for mutually beneficial international electives in LMICs for HIC orthopaedic trainees.